Join to View Full Profile
1625 N Campbell AveTucson, AZ 85719
Phone+1 520-694-0111
Dr. Savir-Baruch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineResidency, Nuclear Medicine, 2011 - 2014- Emory University School of MedicineInternship, Surgery, 2010 - 2011
Semmelweis UniversityClass of 2007
Certifications & Licensure
GA State Medical License 2014 - 2027
AZ State Medical License 2021 - 2026
IL State Medical License 2014 - 2026
American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2015
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015
Clinical Trials
- 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment Start of enrollment: 2016 Jun 01
- Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. Start of enrollment: 2018 Nov 14
- BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy Start of enrollment: 2018 May 29
Publications & Presentations
PubMed
- Summary: SNMMI/ACNM Procedure Standard for Posttreatment Imaging ofLu-Based Radiopharmaceuticals.Carlos Uribe, Amir Iravani, Bital Savir-Baruch, Heather Jacene, Stephen A Graves
Journal of Nuclear Medicine. 2025-10-01 - Index Hepatic Decompensation: Hepatic Hydrothorax Without Signs of Clinically Significant Portal Hypertension Diagnosed With Radioisotope Scintigraphy.Alisia C Gunderson, Brendan Andres, Joseph R Gunderson, Carl Sabottke, Bital Savir-Baruch
ACG Case Reports Journal. 2025-09-01 - Beyond the: PET/MRI UsingGa-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer Treatment.Bital Savir-Baruch, Ephraim Parent
AJR. American Journal of Roentgenology. 2025-01-01
Books/Book Chapters
Press Mentions
Beyond the AJR: PET/MRI Using 68Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients with Biochemical Failure After Prostate Cancer TreatmentMay 15th, 2024- Independent Clinical Studies Published Regarding Performance of Axumin® (Fluciclovine F 18) PET Imaging in Patients with Recurrent Prostate Cancer Undergoing Androgen Deprivation Therapy (ADT)July 19th, 2022
- High Rate of Distant Metastases ID’d After PSMA-PET-Guided sRTJune 21st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
